Samyang Biopharm Corporation (KRX:0120G0)
South Korea · Delayed Price · Currency is KRW 49,050
-750 (-1.51%)
At close: Sep 11, 2026
Samyang Biopharm Market Cap
Samyang Biopharm has a market cap or net worth of 364.36 billion as of September 11, 2026.
Market Cap
364.36B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
49,050.00
ChartMarket Cap Chart
Since November 24, 2025, Samyang Biopharm's market cap has increased from 224.56B to 364.36B, an increase of 62.25%. That is a compound annual growth rate of 83.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 364.36B | -6.67% |
| Dec 30, 2025 | 390.38B | 73.84% |
| Nov 24, 2025 | 224.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioNote | 480.85B |
| i-SENS | 477.64B |
| T&L Co., Ltd. | 448.79B |
| WON TECH | 428.80B |
| DRTECH | 420.72B |
| Curexo | 337.09B |
| ToolGen | 304.49B |
| Value Added Technology | 265.74B |